Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 10/2009

01-10-2009 | Research Articles

Loco-regional control after postoperative radiotherapy for patients with regional nodal metastases from melanoma

Authors: Carlos Conill, Izaskun Valduvieco, Josep Domingo-Domènech, Pedro Arguis, Sergi Vidal-Sicart, Antonio Vilalta

Published in: Clinical and Translational Oncology | Issue 10/2009

Login to get access
Metadata
Title
Loco-regional control after postoperative radiotherapy for patients with regional nodal metastases from melanoma
Authors
Carlos Conill
Izaskun Valduvieco
Josep Domingo-Domènech
Pedro Arguis
Sergi Vidal-Sicart
Antonio Vilalta
Publication date
01-10-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 10/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-009-0425-8

Other articles of this Issue 10/2009

Clinical and Translational Oncology 10/2009 Go to the issue

Case Reports

Choroidal metastases from lung adenocarcinoma

Research Articles

Incidence of oral mucositis, its treatment and pain management in patients receiving cancer treatment at Radiation Oncology Departments in Spanish hospitals (MUCODOL Study)

Educational Series

Adding more content to screening: reactivation of FOXO as a therapeutic strategy

Research Articles

How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?

Educational Series

Prognostic and predictive factors and genetic analysis of early breast cancer

Research Articles

Radiosurgery and whole brain therapy in the treatment of brainstem metastases
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits